Evaluating Drug–Drug Interactions in Cancer Patients Receiving Anticoagulants and Antineoplastics
Despoina Pantazi, Teaching Staff at the Department of Chemistry, University of Ioannina, shared a post on LinkedIn:
“Take a look at my new article!
“Evaluating DDIs in cancer patients receiving anticoagulants and antineoplastics: a scoping review focusing on therapeutic efcacy and safety”
Medical Oncology (2025) 42:511
Many thanks to all participants in this work:
The oncologists:
Dr Melina Gerolatsite, Nanteznta Torounidou, Prof Davide Mauri, and Dr Nikos Tsoukalas
The hematologists:
Prof Grigoris Gerotziafas and Prof Elmina Lefkou
The cardiologist:
Costas Pappas, University Hospital of Ioannina
And
Emeritus professor Alexandros Tselepis for his comments.”
Title: Evaluating DDIs in cancer patients receiving anticoagulants and antineoplastics: a scoping review focusing on therapeutic efficacy and safety
Authors: Melina Yerolatsite, Nikolaos Tsoukalas, Grigoris Gerotziafas, Costas Pappas, Nanteznta Torounidou, Eleftheria Lefkou, Davide Mauri, Alexandros D. Tselepis, Despoina Pantazi
Read full article here.
Stay updated on the latest scientific advancements with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis